Log in - Help - July 25, 2008
CHE logo The Collaborative on Health and the Environment
You are here:  Home » Autism » Scientific References
This site WWW
WHAT'S NEW

Now available: MP3 recording and other resources from the July CHE Partnership Call on how industrial animal production impacts health and the environment" - July 15, 2008 


Also available: resources from the recent call on environmental impacts on autoimmune diseases - July 1, 2008


Recently released: Proceedings from the 2007 UCSF-CHE Fertility Summit (published in the journal of Fertility and Sterility)


5/20/08: The New York Times on BPA: "A Hard Plastic is Raising Hard Questions"

5/9/08: CHE featured in AARP: "The Body Toxic"

5/9/08: CHE Partner Dr. Philip Landrigan interview in Discover: "How Much Do Chemicals Affect Our Health?"


5/5/08: Breast cancer and chemical exposures: new documents from HEAL and CHEM Trust (translations in 6 languages)

4/15/08: Now available: State of the Evidence 2008: The Connection Between Breast Cancer and the Environment

2/20/08: CHE LDDI scientific consensus statement on environmental factors. 

9/1/07: The BioInitiative Report: A Rationale for a Biologically-based Public Exposure Standard for Electromagnetic Fields


Add your events and announcements to the CHE website.


CHE Consensus Statements


CHE Partners on why they value our work
 

Autism: Scientific References

Accardo P, Bostwick H. Zebras in the living room: the changing faces of autism. J Pediatr 135(5):533-535, 1999.

Afzal N, Murch S, Thirrupathy K, et al. Constipation with acquired megarectum in children with autism. Pediatrics 112(4):939-942, 2003.

Alberti A, Pirrone P, Elia M, et al. Sulphation deficit in “low functioning” autistic children: a pilot study. Biol Psychiatry 46:420-424, 1999.

Allred M, Wilbur S. Hazardous substance exposures and autism. In: Advances in Modern Toxicology; ed: DeRosa C, Holler J, Mehlman M. Princeton NJ; International Toxicology Books, Inc.;2002.

Aronson M, Hagberg B, Gillberg C. Attention deficits and autistic spectrum problems in children exposed to alcohol during gestation: a follow-up study. Dev med Child Neurol 39(9):583-587, 1997.

Ashwood P, Anthony A, Pellicer A, et al. Intestinal lymphocyte populations in children with regressive autism: evidence for extensive mucosal immunopathology. J Clin Immunol 23:504-517, 2003.

Bailey A, Le Couteur A, Gottesman I, et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med 25:63-77, 1995.

Bauman M, Kemper T. Histo-anatomic observations of the brain in early infantile autism. Neurology 35:866-874.

Blaxill M, Baskin D, Spitzer W. Commentary: Blaxill, Baskin, and Spitzer on Croen et al. (2002), The changing prevalence of autism in California. J Autism Devel Disorders 33(2):223-226, 2003.

Burger R, Warren R. Possible immunogenetic basis for autism. Ment Retard Dev Disabil Res Rev 4:137-141, 1998.

California Health and Human Services. Dept of Developmental Services. Changes in the population of persons with autism and pervasive developmental disorders in California’s developmental services system:1987-1998. A report to the legislature. Mar, 1999.

Chen R, DeStefano F. Vaccine adverse events: causal or coincidental. Lancet 351:611, 1998.

Christianson A, Chesler N, K Kromberg J. Fetal valproate syndrome: Clinical and neurodevelopmental features in two sibling pairs. Devel Med Child Neurol 36:361-369, 1994.

Colman E. Mercury in infants given vaccines containing thimerosal. Correspondence. Lancet 361:698, 2003.

Comi A, Zimmerman A, Frye V, et al. Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J Child Neurol 14:388-394, 1999.

Courchesne E, Karns CM, Davis HR, et al. Unusual brain growth patterns in early life in patients with autistic disorder: an MRI study. Neurology 57(2):245-254, 2001.

Croen L, Grether J, Hoogstrate J, Selvin S. The changing prevalence of autism in California. J Autism Devel Disorders 32:207-215, 2002.

Croen L, Grether J. Response: A response to Blaxill, Baskin, and Spitzer on Croen et al. (2002), “The changing prevalence of autism in California.” J Autism Devel Disorders 33(2):227-229, 2003.

Desmond M, Wilson g, Melnick J, et al. Congenital rubella encephalitis. Course and early sequelae. J Pediatrics 71:311-331, 1967.

D’Eufemia P, Celli M, Finocchiario R, et al. Abnormal intestinal permeability in children with autism. Acta Pediatr 85:1076-1079, 1996.

DiLavore P, Lord C, Rutter M. Pre-linguistic autism diagnostic observation schedule (PL-ADOS). J Autism Dev Disorders 25:355-379, 1995.

Edelson S, Cantor D. Autism: xenobiotic influences. Toxicol Industr Health 14(4):553-563, 1998.

Eisenberg L. The fathers of autistic children. Am J Orthopsychiat 127:715-724, 1957.

Folstein S, Rosen-Sheidley B. Genetics of autism: complex aetiology for a heterogeneous disorder. Nature Reviews/Genetics 2:943-955, 2001.

Fombonne E. The prevalence of autism. JAMA 289:87-89,2003.

Geier M, Geier D. Thimerosal in childhood vaccines, neurodevelopmental disorders, and heart disease in the United States. J Amer Physicians Surgeons 8(1):6-11, 2003.

Gillberg C, Billstedt E. Autism and Asperger syndrome:coexistence with other clinical disorders. Acta Psychiatr Scand 102(5):321-330, 2000.

Gupta S. Immunological treatments for autism. J Autism Dev Disorders 30:475-479, 2000.

Halsey N, Goldman L. Mercury in infants given vaccines containing thimerosal. Correspondence. Lancet 361:699, 2003.

Harris S, MacKay L, Osborne J. Autistic behaviors in offspring of mothers abusing alcohol and other drugs: a series of case reports. Alcohol Clin Exp Res 19:660-665, 1995.

Hornig M, Chian D, Lipkin W. Neurotoxic effects of postnatal thimerosal are mouse strain dependent. Mol Psychiatry, 2004. [Epub ahead of print].

Horvath K, Papadimitriou J, Rabsztyn A, et al. Gastrointestinal abnormalities in children with autistic disorder. J Pediatr 135(5):559-563, 1999.

Institute of Medicine. Immunization safety review. Measles-mumps-rubella vaccine and autism. Washington DC: National Academy Press; 2001a.

Institute of Medicine. Immunization safety review. Thimerosal-containing vaccines and neurodevelopmental disorders. Washington DC: National Academy Press; 2001b.

Institute of Medicine. Immunization Safety Review. Vaccines and autism. Washington DC: National Academy Press; 2004.

Jyonouchi H, Sun S, Le H. Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. J Neuroimmunol 120:17-179, 2001.

LeCouteur A, Rutter M, Lord C, et al. Autism diagnostic interview: a semi-structured interview for parents and caregivers of autistic persons. J Autism Dev Disorders 19:363-387, 1989.

Lainhart J, Priven J, Wzorek M, et al. Macrocephaly in children and adults with autism. J Am Acad Child Adolesc Psychiatr 36:282-290, 1997.

Moore S, Turnpenny P, Quinn A, et al. A clinical study of 57 children with fetal anticonvulsant syndrome. J Med Genetics 37, 489-497, 2000.

Pichichero M, Cernichiari E, Lopreiato, Treanor J. Mercury concentrations and metabolism in infants receiving vaccines containing thimerosal: a descriptive study. Lancet 360:1737-1741, 2002.

Rapin I. Autism. New Engl J Med 337(2):97-104, 1997.

Ritvo E, Mason-Brothers A, Freeman B, et al. The UCLA-University of Utah epidemiologic survey of autism: the etiologic role of rare diseases. Am J Psychiatry 147:1614-1621, 1990.

Rodier P, Ingram J, Tisdale B, et al. Embryological origins for autism: developmental abnormalities of the cranial nerve motor nuclei. J Comp Neurol 370:247-261, 1996.

Rutter M, Bailey A, Siminoff E, Pickles A. Genetic influences and autism. In: Cohen D, Volkmar F. eds: Handbook of autism and pervasive developmental disorders, 2 nd edition. New York: Wiley , 1997: 370-387.

Singh V, Fudenberg H, Emerson D, Coleman M. Immunodiagnosis and immunotherapy in autistic children. Ann NY Acad Sci 540:602-604, 1988.

Singh V, Warren R, Odell J, Cole P. Changes of soluble interleukin-2, interleukin-2 receptor, T8 antigen, and interleukin-1 in the serum of autistic children. Clin Immunol Immunopathol 61:448-455, 1991.

Steffenberg, S, Gillberg C, Hellgren L, et al. A twin study of autism in Denmark, Finland, Iceland, Norfway, and Sweden. J Child Psychology and Psychiatry 30:405-416, 1989.

Stromland K, Nordin V, Miller B, et al. Autism in thalidomide embryopathy: a population study. Devel Med Child Neurol 36(4):351-356, 1994.

Torrente F, Anthony A, Heuschkel R, et al. Focal-enhanced gastritis in regressive autism with features distinct from Crohn’s and Heliobacter pylori gastritis. Am J Gastroenterol 99:598-605, 2004.

Wakefield A, Murch S, Anthony A, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 351:637-641, 1998.

Waring R. Biochemical parameters in autistic children. Dev Brain Dysfunc 10:40-43, 1997.

Westphal G, Hallier E. Mercury in infants given vaccines containing thimerosal. Correspondence. Lancet 361:699, 2003.

Williams G, King J, Cunningham M, et al. Fetal valproate syndrome and autism: additional evidence of an association. Develop Med Child Neurol 43(3):202-206, 2001.

Wing L. The definition and prevalence of autism: a review. Eur Child Adolesc Psychiatry 2:61-74, 1993.

Woodhouse W, Bailey A, Rutter M, Bolton P, Baird G, Le Couteur A. Head circumference in autism and other pervasive developmental disorders. Child Psychol Psychiatry 37(6):665-671, 1996.

Yeargin-Allsopp M, Rice C, Karapurkar T, et al. Prevalence of autism in a US metropolitan area. JAMA 289(1):49-55, 2003.

 

 

 

 

The Collaborative on Health and the Environment
c/o Commonweal, PO Box 316, Bolinas, CA 94924
For questions or comments about the website, email: info@healthandenvironment.org